Refractory Malignant Ascites
5 clinical trials · Condition
◉ Watch Refractory Malignant Ascites
| Record | Firm | Date |
|---|---|---|
| Oncolytic Virotherapy Plus PD-1 Inhibitor for Patients With Refractory Malignant Ascites (NCT05303844) | Fudan University | 2022-04-02 |
| Palliative Care Outcomes in the Management of Malignant Ascites by Interventional Radiology (NCT02477657) | Abramson Cancer Center at Penn Medicine | 2021-07-01 |
| Intraperitoneal Injection of Oncolytic Viruses H101 for Patients With Refractory Malignant Ascites (NCT04771676) | Fudan University | 2021-03-05 |
| Analysis of Patients Treated With Bevacizumab Intraperitoneal for the Treatment of Refractory Malignant Ascites (NCT02891369) | Fondation Hôpital Saint-Joseph | 2015-02-01 |
| Phase I Trial of Intraperitoneal Bevacizumab in Refractory Malignant Ascites (NCT01852409) | Peking University | 2013-05-01 |
Track Refractory Malignant Ascites automatically
Every clearance here is in the API, with alerts when new ones post.